References
- Anstice, S., Strike, C. J., & Brands, B. (2009). Supervised methadone consumption: Client issues and stigma. Subst Use Misuse, 44(6), 794–808.
- Bart, G. (2012). Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases, 31(3), 207–225.
- Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007). Release from prison—A high risk of death for former inmates. The New England Journal of Medicine, 356(2), 157–165.
- Binswanger, I. A., Nowels, C., Corsi, K. F., Glanz, J., Long, J., Booth, R. E., & Steiner, J. F. (2012). Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors. Addiction Science & Clinical Practice, 7, 3.
- Carrieri, M. P., Amass, L., Lucas, G. M., Vlahov, D., Wodak, A., & Woody, G. E. (2006). Buprenorphine use: The international experience. Clinical Infectious Diseases, 43( Suppl 4), S197–215.
- Clark, R. E., Baxter, J. D., Aweh, G., O'Connell, E., Fisher, W. H., & Barton, B. A. (2015). Risk factors for relapse and higher costs among medicaid members with opioid dependence or abuse: Opioid agonists, comorbidities, and treatment history. Journal of Substance Abuse Treatment, 57, 75–80.
- Darke, S., Larney, S., & Farrell, M. (2017). Yes, people can die from opiate withdrawal. Addiction, 112(2), 199–200.
- Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., et al. (2013). Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010. Lancet, 382(9904), 1564–1574.
- Fiscella, K., Pless, N., Meldrum, S., & Fiscella, P. (2004). Alcohol and opiate withdrawal in US jails. American Journal of Public Health, 94(9), 1522–1524.
- Grogan, C. M., Andrews, C., Abraham, A., Humphreys, K., Pollack, H. A., Smith, B. T., & Friedmann, P. D. (2016). Survey highlights differences in medicaid coverage for substance use treatment and oud medications. Health Aff (Millwood), 35(12), 2289–2296.
- Harris, J., & McElrath, K. (2012). Methadone as social control: Institutionalized stigma and the prospect of recovery. Qualitative Health Research, 22(6), 810–824.
- Jones, C. M., Campopiano, M., Baldwin, G., & McCance-Katz, E. (2015). National and state treatment need and capacity for opioid agonist medication-assisted treatment. American Journal of Public Health, 105(8), e55–63.
- Larney, S., & Dolan, K. (2009). A literature review of international implementation of opioid substitution treatment in prisons: Equivalence of care? European Addiction Research, 15(2), 107–112.
- Luthra, S. (2017). Facing pressure, insurance plans loosen rules for covering addiction treatment. Kaiser Health News. February 21, Retrieved from http://khn.org/news/facing-pressure-insurance-plans-loosen-rules-for-covering-addiction-treatment/ Accessed on April 14, 2017.
- Marsden, J., Stillwell, G., Jones, H., Cooper, A., Eastwood, B., Farrell, M., Lowden, T., Maddalena, N., Metcalfe, C., Shaw, J., & Hickman, M. (2017). Does exposure to opioid substitution treatment in prison reduce the risk of death afterrelease? A national prospective observational study in England. Addiction, 112(8), 1408–1418. doi: 10.1111/add.13779
- Massachusetts Department of Public Health. (2016). Data brief: An assessment of opioid-related deaths in massachusetts 2013–2014. Posted September, Retrieved from http://www.mass.gov/eohhs/docs/dph/stop-addiction/chapter-55-opioid-overdose-study-data-brief-9-15-2016.pdf Accessed on April 13, 2017.
- Merrill, J. O., Jackson, T. R., Schulman, B. A., Saxon, A. J., Awan, A., Kapitan, S., Carney, M., Brumback, L. C., & Donovan, D. (2005). Methadone medical maintenance in primary care. An implementation evaluation. Journal of General Internal Medicine, 20(4), 344–349.
- Olsen, Y., & Sharfstein, J. M. (2014). Confronting the stigma of opioid use disorder–and its treatment. JAMA, 311(14), 1393–1394.
- Peterson, J. A., Schwartz, R. P., Mitchell, S. G., Reisinger, H. S., Kelly, S. M., O'Grady, K. E., Brown, B. S., & Agar, M. H. (2010). Why don't out-of-treatment individuals enter methadone treatment programs? International Journal of Drug Policy, 21(1), 36–42.
- PEW Charitable Trusts. (2017). The case for medication-assisted treatment. Feb. Retrieved from http://www.pewtrusts.org/∼/media/assets/2017/02/thecasemedicationassistedtreatment.pdf Accessed on April 13, 2017.
- Rothwell, J. (2015). Drug offenders in American prisons: The critical distinction between stock and flow. Brookings Institution. Retrieved from https://www.brookings.edu/blog/social-mobility-memos/2015/11/25/drug-offenders-in-american-prisons-the-critical-distinction-between-stock-and-flow/ Accessed on April 13, 2017.
- Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016). Increases in drug and opioid-involved overdose deaths — United States, 2010–2015. MMWR Morbidity and Mortality Weekly Report, ePub, 16 December. Retrieved from https://www.cdc.gov/mmwr/volumes/65/wr/mm655051e1.htm
- SAMHSA Physician and Program Data, (2016). Retrieved from https://www.samhsa.gov/programs-campaigns/medication-assisted-treatment/physician-program-data Accessed on April 13, 2017.
- Schwartz, R. P., Gryczynski, J., O'Grady, K. E., Sharfstein, J. M., Warren, G., Olsen, Y., Mitchell, S. G., & Jaffe, J. H. (2013). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. American Journal of Public Health, 103(5), 917–922.
- Senate Committee on Finance. (2016). Dying waiting for treatment: The opioid use disorder treatment gap and the need for funding. A report by the Democratic Staff of the Senate Committee on Finance. October 10, Retrieved from https://www.finance.senate.gov/imo/media/doc/101116%20Opioid%20Treatment%20Gap%20Report%20Final.pdf Accessed on April 13, 2017.
- Stein, B. D., Sorbero, M., Dick, A. W., Pacula, R., Burns, R. M., & Gordon, A. J. (2016). Physician capacity to treat opioid use disorder with buprenorphine-assisted treatment. JAMA, 316(11), 1211–1212.
- Szalavitz, M. (2015). How america overdosed on drug courts. May 18, Retrieved from https://psmag.com/how-america-overdosed-on-drug-courts-a813ff745a6e#.jj3ds44c4 Acce-ssed on April 13, 2017.
- United Nations Office on Drugs and Crime/World Health organization (UNODC/WHO). (2013). Opioid Overdose: Preventing and reducing opioid overdose mortality. Retrieved from https://www.unodc.org/docs/treatment/overdose.pdf Accessed on April 13, 2017.
- Wakeman, S. E., & Rich, J. D. (2015). Addiction treatment within U.S. correctional facilities: Bridging the gap between current practice and evidence-based care. Journal of Addictive Diseases, 34(2,3), 220–225.
- Wakeman, S. E. (2016). Using science to battle stigma in addressing the opioid epidemic: opioid agonist therapy saves lives. American Journal of Medicine, 129(5), 455–456.
- Wakeman, S. E. (2017). Medications for addiction treatment: Changing language to improve care. Journal of Addiction Medicine, 11(1), 1–2.
- Wakeman, S. E., & Rich, J. D. (2017). Barriers to post-acute care for patients on opioid agonist therapy; An example of systematic stigmatization of addiction. Journal of General Internal Medicine, 32(1), 17–19
- White, W. L., & Mojer-Torres, L. (2010). Recovery-oriented methadone maintenance. Retrieved from http://www.smmgp.org.uk/download/rcgp-certificates/cert04/cert04-p09-d01.pdf Accessed on April 13, 2017.
- The World Health Organization (WHO). The Methadone Fox. (2008). Bulletin of the World Health Organization, 86(3), 161–240. Retrieved from http://www.who.int/bulletin/volumes/86/3/08-050308.pdf on August 22, 2017.